Today on DrugResearcher.com   Antibody alternatives continue to pull in the cash Isis and Alnylam launch microRNA spin-out Cisbio to brighten screening technology Erectile dysfunction drug deemed a flop Merck in search of Korean deal

Related Industry News   Merck, Crucell strengthen vaccine partnership AMRI launches new early-stage Indian facility FluMist finally on track Patheon continues to show the strain of Puerto Rico

Breaking News on Drug Discovery
Daily  Monday 10 September 2007		Forward to a colleague

	Access Full Stories Antibody alternatives continue to pull in the cash Ablynx, one of the two main players in the miniature antibody sector, has signed 'by far' the biggest deal in its history, to help Boehringer Ingelheim develop up to ten so called 'Nanobodies'... Read Isis and Alnylam launch microRNA spin-out Two specialists in the field of RNA-based drug discovery have decided to launch a joint spin-out company to focus solely on microRNA (miRNA) research... Read Cisbio to brighten screening technology Cisbio has entered into a partnership agreement with Lumiphore to gain access to new fluorescence reporter molecules for use in its high throughput (HT) screening assays... Read Erectile dysfunction drug deemed a flop King Pharmaceuticals has ended its alliance with Palatin Technologies, shortly after regulators raised 'serious concerns' over the first-in-class erectile dysfunction drug which was the subject of the collaboration... Read Merck in search of Korean deal Merck & Co. is planning to reach further into the Korean market and is looking for potential deals with biotech companies in the country, according to local media... Read
	All News Headlines for: September | August | July
	Related Industry News Merck, Crucell strengthen vaccine partnership Dutch firm Crucell has strengthened its relationship with Merck & Co, granting the pharma heavyweight exclusive use of its popular PER.C6 technology in two disease areas... Read AMRI launches new early-stage Indian facility US firm Albany Molecular Research (AMRI) has opened a new multimillion dollar research and development facility in Hyderabad, India, confirming its commitment to the region. ... Read FluMist finally on track Manufacturing problems hindering production of MedImmune's intranasal flu vaccine FluMist have finally been resolved at the company's Liverpool, UK facility, with doses on track to be available for this year's... Read Patheon continues to show the strain of Puerto Rico Patheon's third quarter results continue to show the strain of the company's underperforming Puerto Rican operation... Read Weekly comment Chinese scientists given freedom to fail As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according to a state media report this week. Read Previous Headlines eMolecules opens the ChemGate for spectral access eMolecules launched a new web-based database, ChemGate, that contains over 700,000 spectra that Wiley-VCH has collected for over 500,000 molecules... Read Humanised antibodies lead the way in cancer approvals A new report by the Tufts Center has claimed that while the number of anticancer therapies entering clinical development has doubled the approval rate has more than halved... Read UK gets go-ahead for hybrid embryo research Eight months after the debate started over whether hybrid embryo research should be allowed in the UK, the HFEA has given researchers the thumbs up - but only on a case-by-case basis... Read Evotec co-launches European drug research hub Evotec has launched a drug discovery hub in Hamburg in collaboration with the German city in a bid to provide services to academic research institutes of the same quality of those offered to the pharma industry... Read IonGate and LIVC to push screening to the next level High-throughput (HT) screening expert IonGate will assist start-up LIVC with the development and marketing of its novel light-activated ion channel switching technology... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com